Conference Reports

The International Liver Congress™ 2019 (ILC 2019)

Vienna, Austria

10 April 2019 - 14 April 2019

12th IDF-WPR Congress & 10th AASD Scientific Meeting

Kuala Lumpur

22 November 2018 - 25 November 2018

2018 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium

San Francisco, California, US

18 January 2018 - 20 January 2018

Asia Pacific Digestive Week 2017 (APDW 2017)

Hong Kong

23 September 2017 - 26 September 2017

Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!

Understanding disease pathology and drug selection to maximise outcomes in schizophrenia treatment

20 Jun 2020

The Lundbeck Neuroscience Symposium was held at Sofitel KL Damansara over 2 days, with extensivediscussions on the management of various mental illnesses. The second day of the symposiumaddressed the topic of schizophrenia management, focusing on treatment goals, the rationale forpartial dopamine D(2) receptor agonism and the use of long-acting injectable (LAI) antipsychotics topromote adherence.

Migraine a risk factor for dementia?

Pearl Toh, 5 days ago

Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.

Daily alcohol intake, certain drugs tied to liver abnormalities in PsA patients

4 days ago

Patients with psoriatic arthritis (PsA) often suffer from liver abnormalities, which are associated with higher body mass index (BMI), daily consumption of alcohol, more severe disease, and some therapies, according to a recent study.

Pembrolizumab + chemo improves PFS in previously untreated, advanced TNBC

Christina Lau, 2 days ago

Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.